Your browser doesn't support javascript.
loading
Coverage of Novel Therapeutic Agents by Medicare Prescription Drug Plans Following FDA Approval.
Shaw, Daniel L; Dhruva, Sanket S; Ross, Joseph S.
Affiliation
  • Shaw DL; 1 Yale School of Medicine, New Haven, Connecticut.
  • Dhruva SS; 2 Robert Wood Johnson Foundation Clinical Scholars Program, Yale School of Medicine, New Haven, Connecticut, and Veterans Affairs Connecticut Healthcare System, West Haven.
  • Ross JS; 3 Robert Wood Johnson Foundation Clinical Scholars Program and Section of General Internal Medicine, Department of Internal Medicine, Yale School of Medicine; Department of Health Policy and Management, Yale School of Public Health; and Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut.
J Manag Care Spec Pharm ; 24(12): 1230-1238, 2018 Dec.
Article in En | MEDLINE | ID: mdl-30479199
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Topics: Acesso_medicamentos_insumos_estrategicos Health context: 1_ASSA2030 Database: MEDLINE Main subject: United States Food and Drug Administration / Drug Approval / Insurance Coverage / Medicare Part D / Prescription Drugs Type of study: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Country/Region as subject: America do norte Language: En Journal: J Manag Care Spec Pharm Year: 2018 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Topics: Acesso_medicamentos_insumos_estrategicos Health context: 1_ASSA2030 Database: MEDLINE Main subject: United States Food and Drug Administration / Drug Approval / Insurance Coverage / Medicare Part D / Prescription Drugs Type of study: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Country/Region as subject: America do norte Language: En Journal: J Manag Care Spec Pharm Year: 2018 Document type: Article